AstraZeneca Pharma India Discloses Pending Litigation to NSE
AstraZeneca Pharma India has submitted regulatory intimation to the National Stock Exchange regarding pending litigation and disputes affecting the company.
Read articleAI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.
1 articles published
Results for “ASTRAZEN” · in Market Updates — Clear filters
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.